Why is Medicamen Biotec falling/rising?

As of 22-Sep, Medicamen Biotech Ltd's stock price is currently at Rs. 322.00, reflecting a decrease of Rs. 11.8 or 3.54%. The stock has reached a new 52-week low today and has been on a downward trend, having fallen for the last three consecutive days, resulting in a total decline of 5.71% during this period. Additionally, the stock has underperformed its sector by 2.46%. Over the past week, the stock has decreased by 6.12%, and year-to-date, it has seen a significant drop of 36.77%. The stock is trading below all its moving averages, indicating a bearish trend, and there has been a notable decline in investor participation, with delivery volume dropping by 59.59% compared to the five-day average.
In the broader market context, the Sensex has shown a positive return of 0.46% over the past week, contrasting sharply with Medicamen Biotech's performance. This divergence highlights the stock's underperformance relative to the benchmark index. While the Sensex has gained 5.15% year-to-date, Medicamen Biotech's substantial decline suggests company-specific challenges that are not affecting the broader market. Overall, the combination of falling prices, reduced trading volume, and negative performance relative to both the sector and the market indicates a lack of investor confidence in Medicamen Biotech Ltd at this time.